PERTH, Australia – Although industry stakeholders were generally supportive of New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) proposed changes to the reclassification system for drugs in New Zealand, most vehemently opposed the idea of posting completed applications on the Medsafe website, citing competitive intellectual property concerns.